Reaction Details |
| Report a problem with these data |
Target | Prothrombin |
---|
Ligand | BDBM50193227 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_381888 (CHEMBL870372) |
---|
IC50 | 10050±n/a nM |
---|
Citation | De Nanteuil, G; Gloanec, P; Béguin, S; Giesen, PL; Hemker, HC; Mennecier, P; Rupin, A; Verbeuren, TJ Low molecular weight activated protein C inhibitors as a potential treatment for hemophilic disorders. J Med Chem49:5047-50 (2006) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Prothrombin |
---|
Name: | Prothrombin |
Synonyms: | Activation peptide fragment 1 | Activation peptide fragment 2 | Coagulation factor II | F2 | Prothrombin precursor | THRB_HUMAN | Thrombin heavy chain | Thrombin light chain |
Type: | Protein |
Mol. Mass.: | 70029.57 |
Organism: | Homo sapiens (Human) |
Description: | P00734 |
Residue: | 622 |
Sequence: | MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLEREC
VEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHV
NITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQE
CSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASA
QAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETG
DGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYI
DGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEN
DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP
VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST
RIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKY
GFYTHVFRLKKWIQKVIDQFGE
|
|
|
BDBM50193227 |
---|
n/a |
---|
Name | BDBM50193227 |
Synonyms: | CHEMBL214264 | {(R)-1-[2-(4-carbamimidoyl-benzylcarbamoyl)-indan-2-ylcarbamoyl]-2-phenyl-ethylamino}-acetic acid |
Type | Small organic molecule |
Emp. Form. | C29H31N5O4 |
Mol. Mass. | 513.5875 |
SMILES | NC(=N)c1ccc(CNC(=O)C2(Cc3ccccc3C2)NC(=O)[C@@H](Cc2ccccc2)NCC(O)=O)cc1 |
Structure |
|